Literature DB >> 19797745

Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis.

James D Heffelfinger1, Pragna Patel, John T Brooks, Helene Calvet, Charles L Daley, Hazel D Dean, Brian R Edlin, Kathleen F Gensheimer, John Jereb, Charlotte K Kent, Jeffrey L Lennox, Janice K Louie, Ruth Lynfield, Philip J Peters, Lauretta Pinckney, Philip Spradling, Andrew C Voetsch, Anthony Fiore.   

Abstract

Among vulnerable populations during an influenza pandemic are persons with or at risk for HIV infection, tuberculosis, or chronic viral hepatitis. HIV-infected persons have higher rates of hospitalization, prolonged illness, and increased mortality from influenza compared with the general population. Persons with tuberculosis and chronic viral hepatitis may also be at increased risk of morbidity and mortality from influenza because of altered immunity and chronic illness. These populations also face social and structural barriers that will be exacerbated by a pandemic. Existing infrastructure should be expanded and pandemic planning should include preparations to reduce the risks for these populations.

Entities:  

Mesh:

Year:  2009        PMID: 19797745      PMCID: PMC4504393          DOI: 10.2105/AJPH.2008.158170

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  77 in total

1.  Asian influenza and pulmonary tuberculosis.

Authors:  S LOFGREN; A CALLANS
Journal:  Acta Med Scand       Date:  1959-08-31

2.  Viral hepatitis and other infectious diseases in a homeless population.

Authors:  Ramsey C Cheung; Aspasia K Hanson; Kalyani Maganti; Emmet B Keeffe; Suzanne M Matsui
Journal:  J Clin Gastroenterol       Date:  2002-04       Impact factor: 3.062

3.  Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients.

Authors:  Hikaru Yamanaka; Katsuji Teruya; Mari Tanaka; Yoshimi Kikuchi; Takao Takahashi; Satoshi Kimura; Shinichi Oka
Journal:  J Acquir Immune Defic Syndr       Date:  2005-06-01       Impact factor: 3.731

4.  Pulmonary impairment after tuberculosis.

Authors:  Jotam G Pasipanodya; Thaddeus L Miller; Mauricio Vecino; Guadalupe Munguia; Robert Garmon; Sejong Bae; Gerry Drewyer; Stephen E Weis
Journal:  Chest       Date:  2007-03-30       Impact factor: 9.410

5.  Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season.

Authors:  H M Radwan; S H Cheeseman; K K Lai; R T Ellison III
Journal:  Clin Infect Dis       Date:  2000-08       Impact factor: 9.079

6.  Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1.

Authors:  S A Madhi; B Schoub; K Simmank; N Blackburn; K P Klugman
Journal:  J Pediatr       Date:  2000-07       Impact factor: 4.406

7.  Defective B-lymphocyte function in homosexual men in relation to the acquired immunodeficiency syndrome.

Authors:  S G Pahwa; M T Quilop; M Lange; R N Pahwa; M H Grieco
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

8.  Bronchial stricture due to endobronchial tuberculosis.

Authors:  Y Watanabe; S Murakami; T Iwa
Journal:  Thorac Cardiovasc Surg       Date:  1988-02       Impact factor: 1.827

9.  Management of HIV infection in patients with substance use problems.

Authors:  Ank Nijhawan; Soyun Kim; Josiah D Rich
Journal:  Curr Infect Dis Rep       Date:  2008-09       Impact factor: 3.725

Review 10.  Neuraminidase inhibitors and their role in avian and pandemic influenza.

Authors:  Martin Crusat; Menno D de Jong
Journal:  Antivir Ther       Date:  2007
View more
  3 in total

1.  Protecting vulnerable populations from pandemic influenza in the United States: a strategic imperative.

Authors:  Sonja S Hutchins; Benedict I Truman; Toby L Merlin; Stephen C Redd
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

2.  Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine.

Authors:  Ekaterina Moroz; Randy A Albrecht; Brandon Aden; Ann Bordwine Beeder; Jianda Yuan; Adolfo García-Sastre; Brian R Edlin; Mirella Salvatore
Journal:  Vaccine       Date:  2016-02-06       Impact factor: 3.641

3.  Efficacy of influenza vaccination in patients with cirrhosis and inactive carriers of hepatitis B virus infection.

Authors:  B Sayyad; S M Alavian; F Najafi; T Mokhtari Azad; M H Ari Tabarestani; M Shirvani; B Behnava; M Afshrian; S Vaziri; A R Janbakhsh; F Mansouri; Sh Kaviani
Journal:  Iran Red Crescent Med J       Date:  2012-10-30       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.